Gingival crevicular fluid and serum levels of APRIL, BAFF and TNF-alpha in rheumatoid arthritis and osteoporosis patients with periodontal disease

Archives of Oral Biology

Volumn 58, Issue 10, 2013, Pages 1302-1308

  Gümüş, Pinar ^a   Buduneli, Eralp ^a   Biyikoǧlu, Başak ^a   Aksu, Kenan ^a   Saraç, Fulden ^a   Buduneli, Nurcan ^a   Lappin, David F ^b  

^a EGE UNIVERSITY   (Turkey)

^b GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

Gingival crevicular fluid; Osteoporosis; Periodontal disease; Rheumatoid arthritis; TNF family cytokines serum

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; TNFSF13B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; METABOLISM; MIDDLE AGED; OSTEOPOROSIS; PERIODONTAL DISEASE; RHEUMATOID ARTHRITIS; TNF-FAMILY CYTOKINES SERUM;

GINGIVAL CREVICULAR FLUID; OSTEOPOROSIS; PERIODONTAL DISEASE; RHEUMATOID ARTHRITIS; TNF-FAMILY CYTOKINES SERUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; B-CELL ACTIVATING FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PERIODONTAL DISEASES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888040082     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2013.07.010     Document Type: Article

References (40)

1. Mackler BF, Frostad KB, Robertson PB, Levy BM. Immunoglobulin bearing lymphocytes and plasma cells in human periodontal disease. Journal of Periodontal Research 1977;12(1):37-45.
2. Seymour GJ, Greenspan JS. The phenotypic characterization of lymphocyte subpopulations in established human periodontal disease. Journal of Periodontal Research 1979;14(1):39-46.
3. Seymour GJ, Powell RN, Davies WI. Conversion of a stable Tcell lesion to a progressive B-cell lesion in the pathogenesis of chronic inflammatory periodontal disease: an hypothesis. Journal of Clinical Periodontology 1979;6(5):267-77.
4. Hadj-Kacem H, Rebuffat S, Mnif-Feki M, Belguith-Maalej S, Ayadi H, Péraldi-Roux S. Autoimmune thyroid diseases: genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions. International Journal of Immunogenetics 2009;36(2):85-96.
5. Mackay F, Silveira PA, Brink R. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Current Opinion in Immunology 2007;19 (3):327-36.
6. Pers JO, Saraux A, Pierre R, Youinou P. Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. Journal of Periodontology 2008;79(9):1645-51.
7. Yavuzyilmaz E, Yamalik N, Çalgüner M, Ersoy F, Baykara M, Yeniay I, et al. Clinical and immunological characteristics of patients with rheumatoid arthritis and periodontal disease. Journal of Nihon University School of Dentistry 1992; 34(2):89-95.
8. Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease? Journal of Clinical Periodontology 2000;27(4):267-72.
9. Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. Journal of Periodontology 2001;72 (6):779-87.
10. Yavuzyilmaz E, Yamalik N, Çalgüner M, Ersoy F, Baykara M, Yeniay I. Clinical and immunological characteristics of patients with rheumatoid arthritis and periodontal disease. The Journal of Nihon University School of Dentistry 1992;34(2):89-95.
11. Löfman O, Larsson L, Toss G. Bone mineral density in diagnosis of osteoporosis: reference population, definition of peak bone mass, and measured site determine prevalence. Journal of Clinical Densitometry 2000;3(2):177-86.
12. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumour necrosis factor receptor and ligand families. Endocrine Reviews 1999;20(3):345-57.
13. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclast inhibitory factor and is identical to TRANCE/ RANKL. Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3597-602.
14. Quinn JMW, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. Fibroblastic stromal cells express receptor activator of NFkappa B ligand and support osteoclast differentiation. Journal of Bone and Mineral Research; 2000;15(8):1459-66.
15. Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT. Activated T lymphoctes support osteoclast formation in vitro. Biochemical and Biophysical Research Communications 1999; 265(1):144-50.
16. Lacey DL, Timms E, Tan H-L, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93(2):165-76.
17. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis. Nature 1999;397(6717):315-23.
18. Gümüş P, Buduneli E, Biyikoǧlu B, et al. Gingival crevicular fluid, serum levels of receptor activator of nuclear factorkappa B ligand, osteoprotegerin, interleukin-17 in rheumatoid arthritis and osteoporosis patients with periodontal disease. Journal of Periodontology 2013. http://dx.doi.org/10.1902/jop.2013.120595. (in press [Epub ahead of print]).
19. Le Pottier L, Bendaoud B, Renaudineau Y, Youinou P, Jacques-Olivier Pers J-O, Daridon C. New ELISA for B cell-activating factor. Clinical Chemistry 2009;55 (10):1843-51. 2009.
20. Boström L, Linder LE, Bergström J. Smoking and crevicular fluid levels of IL-6 and TNF-α in periodontal disease. Journal of Clinical Periodontology 1999;26(8):352-7.
21. Howells GL. Cytokine networks in destructive periodontal disease. Oral Diseases 1995;1(4):266-70.
22. Tervahartiala T, Koski H, Xu JW, et al. Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis. Journal of Dental Research 2001;80(7):1535-9. Erratum in: Journal of Dental Research; 80:1684.
23. Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. Journal of Experimental Medicine 1999;189(11):1747-56.
24. Roschke V, Sosnovtseva S, Ward CD, et al. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. Journal of Immunology 2002;169(8):4314-21.
25. Daridon C, Youinou P, Pers JO. BAFF, APRIL, TWE-PRIL: who's who? Autoimmunity Reviews 2008; 7(4):267-71.
26. Bannish G, Fuentes-Panana EM, Cambier JC, Pear WS, Monroe JG. Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. Journal of Experimental Medicine 2001; 194(11):1583-96.
27. Gerondakis S, Strasser A. The role of Rel/NF-κB transcription factors in B lymphocyte survival. Seminars in Immunology 2003;15 (3):159-66.
28. Claudio E, Brown K, Park S, Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nature Immunology 2002;3(10):958-65.
29. Senftleben U, Cao Y, Xiao G, et al. Activation by IKKa of a second, evolutionary conserved, NF-κB signaling pathway. Science 2001;293(5534):1495-9.
30. Khan WN. B Cell Receptor and BAFF receptor signaling regulation of B cell homeostasis. Journal of Immunology 2009;183(6):3561-7. 2009.
31. Yu G, Boone T, Delaney J, Hawkins N, et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nature Immunology 2000; 1(3):252-6.
32. Pers J-O, d'Arbonneau F, Devauchelle-Pensec V, Saraux A, Pennec YL, Youinou P. Is periodontal disease mediated by salivary BAFF in Sjogren's syndrome? Arthritis & Rheumatism 2005;52 (8):2411-4.
33. Onal M, Xiong J, Chen X, et al. Receptor activator of nuclear factor kB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. Journal of Biological Chemistry 2012; 287(35):29851-60.
34. Kikuta J, Wada Y, Kowada T, et al. Dynamic visualization of RANKL and Th17-mediated osteoclast function. Journal of Clinical Investigation 2013. http://dx.doi.org/10.1172/JCI65054. (In press. [Epub ahead of print]).
35. Lappin DF, Koulouri O, Radvar M, Hodge P, Kinane DF. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. Journal of Clinical Periodontology 1999;26(3):183-9.
36. Tew J, Engel D, Mangan D. Polyclonal B-cell activation in periodontitis. Journal of Periodontal Research 1989;24(4): 225-41.
37. Li Y, Toraldo G, Li A, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 2007; 109 (9):3839-48.
38. Khosla S, Minireview:. The OPG/RANKL/RANK system. Endocrinology 2001;142(12):5050-5.
39. Hemingway F, Taylor R, Knowles HJ, Athanasou NA. RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. Bone 2011; 48(4):938-44.
40. Kotsovilis S, Tseleni-Balafouta S, Charonis A, Fourmousis I, Nikolidakis D, Vrotsos JA. Syndecan-1 immunohistochemical expression in gingival tissues of chronic periodontitis patients correlated with various putative factors. Journal of Periodontal Research 2010;45 (4):520-31.